Pricing
  1. US-listed companies
  2. Arcadia Biosciences, Inc.
  3. Financials
  4. Net income margin (%)

Arcadia Biosciences, Inc. (RKDA)

Market cap
$2.52M
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 2022-154.4-28.57%
Dec 31, 2021-216.2+273.18%
Dec 31, 2020-57.9-97.65%
Dec 31, 2019-2,464.1+167.61%
Dec 31, 2018-920.8+136.01%
Dec 31, 2017-390.1-36.62%
Dec 31, 2016-615.6+85.60%
Dec 31, 2015-331.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat